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Abstract.  Tenascin,  an extracellular matrix protein,  is 
expressed in the mesenchyme around growing epithelia 
in the embryo. We therefore investigated whether epi- 
thelial cells can stimulate expression of tenascin in 
embryonic mesenchyme.  Mesenchyme from the pre- 
sumptive small intestine was used because it is known 
that reciprocal epithelial-mesenchymal  interactions are 
important for gut morphogenesis.  Rat monoclonal anti- 
bodies against mouse tenascin were raised and were 
found to react specifically with mouse tenascin in 
ELISA. In supernatants  of cultured fibroblasts, the an- 
tibodies precipitated two peptides of Mr 260 and 210 
kD.  One of the antibodies also reacted with these 
tenascin chains in immunoblots of tissue extracts.  We 
found that tenascin was absent during early stages of 
gut development, at stages when the mesenchyme is 
already in contact with the stratified epithelium of the 
endoderm.  Rather,  it appeared in the mesenchyme 
when the homogenous endodermal epithelium differen- 
tiated into the heterogenous absorptive epithelium. 
Tenascin remained present in the stroma of the adult 
gut, close to the migration pathways of the continu- 
ously renewing epithelium.  When first detected during 
intestinal differentiation,  the 210-kD component was 
predominant but at birth the relative amount of the 
260-kD component had increased.  The expression data 
suggested that the appearance of tenascin in the 
mesenchyme was dependent on the presence of epithe- 
lium.  To test this,  isolated gut mesenchymes from 
13-d-old mouse embryos were cultured for 24 h either 
alone or together with epithelial and nonepithelial 
cells.  Whereas mesenchyme cultured alone or in the 
presence of nonepithelial  B16-F1 melanoma cells pro- 
duced only trace amounts of tenascin,  expression was 
strongly stimulated by the epithelial cell line, 
Madin-Darby canine kidney (MDCK).  We propose 
that growing and differentiating epithelia produce lo- 
cally active factors which stimulate synthesis of tenas- 
cin in the surrounding  mesenchyme. 
T 
EN ASClN is a mesenchymal matrix glycoprotein  with 
an unusually restricted expression pattern in the devel- 
oping embryo (10). Tenascin is probably identical  to 
cytotactin  (21) and similar  proteins  from other species have 
been described in some adult and many embryonic tissues 
(4,  18, 29).  Tenascin  is  selectively  present in the mesen- 
chyme surrounding  growing  epithelia  in organs  where the 
mesenchyme is essential  for epithelial  development.  It has 
therefore been proposed as a mesenchymal signal transducer 
in these interactions  (10). In the developing kidney tenascin 
is absent during  the first inductive  epithelial-mesenchymal 
interactions  (1) and it is therefore probably not a signal trans- 
ducer during  the first inductive  interactions  in this  organ. 
Other molecules present earlier may be more important  in 
this  respect (41). However, tenascin  in the kidney  appears 
shortly after the first interaction,  suggesting that its expres- 
sion is a  consequence of epithelial-mesenchymal  interac- 
tions (1). Such a relationship  may be common and would ex- 
plain the restricted distribution  of tenascin  around growing 
epithelia  in  many  other tissues.  Hence,  we propose that 
actively  growing,  migrating,  and  differentiating  epithelial 
sheets can produce factors that stimulate tenascin expression 
in the nearby mesenchyme.  The immunohistochemical  data 
from other embryonic tissues (10) and epithelial tumors (33) 
fit well with this hypothesis. 
To test this possibility,  we have examined the expression 
of tenascin  in the developing gut.  Data on tenascin  expres- 
sion in this tissue is lacking,  although  it is known that epi- 
thelial-mesenchymal  interactions  are instrumental  for gut 
development (27, 37, 43). Unlike other epithelia,  the gut epi- 
thelium  undergoes continuous rapid renewal  in the adult. 
New epithelial  cells are derived from the proliferating  cells 
of the crypts at the bases of the villi. They then migrate along 
the villus surface and are finally shed into the gut lumen. The 
diversity of proliferating,  differentiating,  and migrating  epi- 
thelial  cells hence makes it possible to test which of these 
epithelial  compartments  possibly stimulate  expression  of 
tenascin. 
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raised mAbs against mouse tenascin.  Two of these mAbs 
were characterized with respect to their ability to bind tenas- 
cin in quantitative ELISA,  immunoprecipitations,  and im- 
munoblots. Both antibodies recognize a protein that under 
reducing conditions dissolves into two peptides with Mr's of 
210 and 260 kD, and they react with mouse tenascin in im- 
munofluorescence of  tissue sections. One of  them also recog- 
nizes the protein in immunoblots of tissue extracts. 
The expression data on embryonic and adult gut obtained 
with the antibodies suggested that tenascin expression in the 
gut mesenchyme may indeed be stimulated by the epithelial 
cells. This hypothesis was then directly tested by coculturing 
embryonic gut mesenchymal cells with established cell lines. 
As judged by immunoprecipitation and immunofluorescence 
assays using the characterized antibodies, tenascin expres- 
sion could be strongly stimulated by the epithelial Madin- 
Darby canine kidney (MDCK) ~  cell line (38) but not by the 
nonepithelial B16-F1 melanoma cell line (20). These results 
provide experimental evidence that epithelial cells can pro- 
mote the expression of tenascin in embryonic mesenchyme. 
Materials and Methods 
Hybridoma Production 
Mouse tenascin, partially purified by affinity chromatography on polyclonal 
rabbit anti-chick tenascin antibodies coupled to CNBr-Sepharose 4B (Phar- 
macia Fine Chemicals, Freiburg, FRG) was a kind gift of Dr. Ruth Chiquet- 
Ehrismann (Friedrich  Miescher Institut,  Basel,  Switzerland).  Approxi- 
mately 20 ~tg of  protein dissolved in PBS and mixed with 1.5 vol of complete 
Freund's adjuvants (Miles Laboratories, Inc., Bedford, MA) for the first im- 
munization and incomplete Freund's adjuvants for additional boosts, were 
injected intraperitoneally into a male Lou-rat at 40, 27,  12, and 5 d before 
fusion. 
For generation of hybridomas, spleen cells and cells from Peyers patches 
were fused with rat Y-Agl.2.3 myeloma cells (a gift of Dr.  R.  Kemler, 
Max-Planck-Institute,  Tiibingen) as described previously  (39).  Fusion prod- 
ucts were seeded on feeder-layers in 96-well culture dishes (Costar, Fern- 
wald, FRG) in DME containing 10% FCS (Biochrom, Berlin, FRG), 10% 
human endothelial cell  supernatant (Costar),  and 2.5%  Ewing sarcoma 
growth factor (Costar). Culture supernatants were removed from 96-well 
plates 1 d after cells had reached confluency and were screened for presence 
of mAbs by ELISA and immunofluorescence. 
Subcloning and Propagation of  Hybridomas 
Cells which produced supernatants with a positive reaction in the ELISA 
and an immunofluorescence-staining  pattern compatible with the one previ- 
ously seen with polyclonal anti-chicken tenascin antibodies were subcloned 
by limited dilution, and rescreened as described above. In addition, immu- 
noglobulin subtypes were identified using a  "rat monoclonal typing kit" 
(ICN Biomedical, Eschwege, FRG). Further propagation of cells and pro- 
duction of supernatants for antibody purification was achieved in DME con- 
raining 1% MCA-1 (Costar). 
Purification of  Monoclonal Antibodies 
Culture medium was diluted 1:4 with 25 mM 2(N-Morpholino)etansulfonic 
acid, pH 4.0, and filtered through a 0.24tm filter.  The filtrate was applied 
to an HR column (Pharmacia Fine Chemicals) packed with Bakerbond ABx 
(Baker Chemical Co., Grol~-Gerau,  FRG) connected to a Pharmacia fast 
protein liquid chromatography system. The column was then washed with 
8 vol of 10 mM 2(N-Morpholino)etansulfonic acid, pH 5.6, and eluted with 
a gradient of 0-100%  1 M Na-Acetate, pH 7.0 (buffer B), over 50 ml. Anti- 
bodies eluted at slightly more than 50% buffer B. Their purity was checked 
1. Abbreviation  used in this paper:  MDCK, Madin-Darby canine kidney. 
by SDS-PAGE using Phastgels 10-15 % (Pharmacia Fine Chemicals) and the 
Pharmacia Phastsystem. 
ELISA 
For the screening procedure and characterization of selected antibodies, 
96-well microtiter plates (Falcon Labware, Heidelberg, FRG) were coated 
with 0.5  gg of immunogen or mouse tenascin. The mouse tenascin was 
purified on mAbs coupled to CNBr-Sepharose (Pharmacia Fine Chemicals) 
affinity columns and blocked with Tris-buffered saline (TBS) containing 4 % 
(wt/vol) BSA and 0.05%  (vol/vol) Tween 20.  Bound antibodies were de- 
tected by  ELISA (17) using the biotin-streptavidin system (Amersham- 
Buchler GmbH, Braunschweig, FRG) with horseradish peroxidase as the 
enzyme and tetramethylbenzidine (Miles Laboratories, Inc./ICN Biomedi- 
cal) as the substrate. Between all incubations, plates were washed exten- 
sively with TBS containing 0.05%  Tween 20 by a Scatron Microwash II. 
l~ssue Dissection and Organ Culture 
Small intestines were obtained from National Medical Research Institute 
(NMRI)x 129 hybrid mice. In these hybrids, the first signs of villus forma- 
tion were seen between days 14 and 15 of gestation (counted from the day 
of the vaginal plug, day 0). For preparation of intestinal mesenchymes, guts 
were dissected from 13-d mouse embryos. They were largely freed of the 
outer muscular layer under a stereo microscope and immersed in PBS with 
0.1 mM EDTA for 30 min. The mesenchymal cell layer was then cut open 
with sharp injection needles, and the endodermal (epithelial) layer was re- 
moved. Explant cultures were grown in DME supplemented  with 10% FCS. 
For this purpose, mesenchymes were placed on Nuclepore filters (pore di- 
ameter 1.0 Bm; Nuclepore, Tfibingen, FRG) coated with gelatin by brief 
submersion in 0.2 % gelatin. When other cells were to be present on the op- 
posite side of the filter,  these were seeded at '~105 ceils per cm  2 1 to 2 d 
before the addition of mesenchymes. Explants on filters were cultured on 
a stainless steel grid as described previously for kidney mesenchyme (14). 
In some experiments, 1% trasylol (Bayer, Leverkusen, FRG) was added to 
the medium to prevent flattening of explants, because it proved to be very 
difficult to get good cryostat sections from the flattened explants. All experi- 
ments involving trasylol were also carried out in the absence of the protease 
inhibitor with the same results. 
Cell Lines 
For coculture experiments, we selected two cell lines not producing tenas- 
cin, but with differing morphologies. These were the nonepithelial cell line 
(Bt6-FI melanoma) with a fibroblastic morphology but of neuroectodermal 
origin (20), and the canine kidney epithelial cell line, MDCK, which forms 
a polarized epithelium (38). Both cell lines were the kind gifts of Drs. W. 
Birchmeier and J. Behrens (Friedrich-Miescher-Laboratorium, Tfibingen, 
FRG). 
lmmunoblotting and Immunoprecipitation 
For immunoblot analysis of tenascin in the developing gut, small intestines 
were extracted at alkaline pH (11) in a buffer containing 200 mM cyclohex- 
ylaminopropane sulfonic acid, pH 11.5, 150 mM NaCl, 1 mM EDTA, 2 mM 
phenylmethanesulfonyl fluoride (PMSF), 1% trasylol, and 4 mM N-ethyl- 
maleimide. Tissues were dissected from the embryo, briefly washed in ice 
cold buffer, transferred to approximately five times its own volume of the 
same buffer, and then disrupted by short ultrasonic treatment (,~2 s) using 
a Branson sonifier with microtip. Extraction was achieved under constant 
agitation at 4°C for 15 rain.  The extract was neutralized by addition of 
NaH2PO4.  For Western blotting (46), the extract was boiled with sample 
buffer and subjected to SDS-PAGE on 5-10% acrylamide gradient gels (31). 
Extraction of tenascin for immunoprecipitations from mesenchymes  cul- 
tared in the transfilter system could efficiently be achieved by sonication of 
the mesencbymes in 500  p.1 of NET buffer (1%  NP-40,  5  mM EDTA, 
50 mM Tris-HCl, pH 8.0, 400 mM NaCI, 1% trasylol, 2 mM PMSF). For 
metabolic labeling, dissected tissues were incubated for 1 h in methionine- 
free  DME  and  then  for 4  h  in  the  same  medium  supplemented with 
[3~S]methionine at a  final specific activity of 37 MBq (1  mCi) per ml of 
medium. In the transfilter experiments, [3H]leucine  was also added at a 
final  specific activity of 3.7 MBq (0.1 mCi) per ml of medium. Immuno- 
precipitations of extracts of such labeled tissues were performed as de- 
scribed by Chiquet-Ehrismann et al. (10), except that protein A-Sepharose 
(Pharmacia Fine Chemicals) was used instead of pansorbin cells, and rabbit 
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to bind rat IgM to protein A. 
lmmunofluorescence 
Embedding, cryostat sectioning, and indirect immunofluorescent staining of 
the unfixed frozen sections of tissues and transfilter cultures were done as 
described previously (1). 
Other Reagents 
The TROMA-I rat mAb which reacts with cytokeratin (6) was a gift from 
Dr. R. Kemler (Friedrich Miescher Laboratorium, Tiibingen, FRG). Goat 
anti-rabbit fibronectin was obtained from Biosciences Products, Emmen- 
brucke, Switzerland and tested for its specificity by immunoprecipitation. 
Mouse fibronectin and mouse collagen type I used in the ELISA were from 
Paesel GmbH (Frankfurt,  FRG) and Calbiochem-Behring Corp.  (Frank- 
furt, FRG), respectively. Biotinylated second antibodies and biotin-strep- 
tavidine-horseradish peroxidase for  the  ELISA  were  from  Amersham- 
Buchler GmbH  and  FITC-  and  RITC-conjugated second antibodies for 
immunofluorescence were flora Jackson Laboratories/Dianova (Hamburg, 
FRG). Other chemicals were from Sigma Chemical GmbH (Munich, FRG) 
unless otherwise indicated. 
Results 
Specificity of  Rat Anti-mouse Tenascin mAbs 
Of the nine independent antibody clones that were positive 
throughout the screening procedure, one with an especially 
brilliant reaction in immunofluorescence, designated MTn 5 
(from the  IgM  class),  and  one with  a  strong  reaction in 
ELISA, designated MTn  12  (IgGt), were selected for fur- 
ther characterization. For this purpose, proteins recognized 
by the antibodies were immunoprecipitated from superna- 
tants of metabolically labeled fibroblasts. The proteins were 
separated by SDS-PAGE under reducing conditions and vi- 
sualized by fluorography (Fig. 1). The pattern obtained, one 
band at 260 kD running slightly higher than fibronectin, and 
one band at 210 kD,  was in agreement with previous data 
from mouse cells using polyclonal anti-chick tenascin anti- 
Figure 1.  Fluorograph of the 
peptides  precipitated  by  the 
mAbs  MTn  5  (lane  1)  and 
MTn 12 (lane 2), and protein 
A-Sepharose  alone (lane 3). 
Mouse embryonic fibroblasts 
at an early passage were la- 
beled for 16 h with 3.7 MBq/ 
ml of [~SS]methionine  and the 
protein precipitated from the 
conditioned supematant. Pre- 
cipitates were separated under 
reducing conditions by SDS- 
PAGE on a linear gradient gel 
(5-10% acrylamide). 
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~gure 2. ELISA demonstrating  specific  binding  of  mAb to  ~nas- 
cin. Bound antibodies were detected by biotinylated goat anti-rat 
antibodies and a biotin-streptavidin-horseradish  peroxidase com- 
plex using an enzyme-catalyzed dye reaction. MTn 5 (an IgM) and 
MTn 12 (an IgG0 bind to tenascin, but not to fibronectin and col- 
lagen type I. Wells of a microtiter plate were coated with 0.5 ~tg 
of protein per well. (o) Antibody MTn 12/substrate tenascin; ([]) 
MTn 5/tenascin; (zx) MTn 12/Collagen Type I; (o) MTn 12/fibro- 
nectin; (*) MTn 5/fibronectin. 
bodies (1). Interestingly, the 260-kD tenascin band always 
predominated in culture supernatants, as has been previously 
reported, while both bands were about equal in intensity in 
precipitates from cell lysates. The antibody MTn 12, but not 
MTn 5, also reacted with tenascin in Western blots (Fig. 5). 
Specificity of antigen-antibody binding was further exam- 
ined by the ELISA method. The antibody was shown to bind 
to the antigen preparation used for immunization (Fig. 2), 
containing mouse tenascin as well as trace amounts of fibro- 
nectin and albumin.  No binding was observed with either 
mouse fibronectin, mouse collagen type I (Fig. 2), or BSA 
(data not shown).  Taken together, the data show that both 
mAbs react specifically with mouse tenascin. 
Appearance of Tenascin in the Embryonic Gut 
Mesenchyme Underlying the Differentiating Epithelia 
Morphogenesis of the gut starts from the intestinal anlage, 
which consists of the endoderm, a simple tube of stratified 
epithelial cells surrounded by mesenchymal cells. In mice 
used in the present study, this stage was reached on day 13 
of embryonic age,  the earliest stages  investigated.  During 
subsequent development, the mesenchyme forms muscular 
and connective tissue layers, as well as the stroma within the 
villi, the lamina propria.  The villus epithelium is derived 
from the endoderm and consists of a single layer of columnar 
ceils (37). To localize tenascin at different stages of intestinal 
development, frozen sections of intestines were examined by 
immunofluorescence. In the early gut anlage of a  13-d-old 
mouse embryo, we found ample expression of fibronectin in 
the mesenchyme which surrounds the stratified endodermal 
epithelium (Fig. 3 a), while tenascin could not be detected 
(Fig. 3 b). The epithelium expressed cytokeratin at this stage, 
as judged  by  immunohistological  staining  for cytokeratin 
with the TROMA  1 antibody (data not shown).  When the 
first endodermal cells evaginated to form villus primordia, 
some faint staining with anti-tenascin antibodies was  seen 
Aufderheide and Ekblom Tenascin Induction  2343 Figure 3. Comparison of fibmnectin (a and c) and tenascin (b and d) expression in presumptive small intestine from day 13 (a and b) 
and 17 (c and d) of embryonic development. In the gut anlage from day 13 of embryonic development, the endoderm (end) forms a hollow 
tube of stratified epithelial cells which is surrounded by the undifferentiated mesenchyme (rues). Fibronectin is already strongly expressed 
by this mesenchyme (a), while tenascin can not be detected (b). At day 17 primitive villi have been formed, which already protrude into 
the lumen. They consist of the mesenchymal core (lamina propria),  which is covered by epithelial cells derived from the endoderm. 
Fibronectin, also at this stage, is evenly distributed throughout the mesenchyme (a). Tenascin is predominantly found in the lamina propria 
of the villi and in a small band within the outer mesenchyme, probably the presumptive muscularis mucosae (d). Bars, 50 Bm. 
in the mesenchyme underlying these areas.  When the first 
primitive villi with a lamina propria could be seen, fibronec- 
tin was still evenly distributed throughout the mesenchyme 
(Fig. 3 c), while tenascin was almost exclusively seen within 
the villi and in a narrow band in the mesenchyme, probably 
the presumptive muscularis mucosae (Fig. 3 d). In the adult 
intestine, tenascin was still present (Fig. 4). Whereas fibro- 
nectin was apparently present around all cells of the adult in- 
testinal  stroma (Fig.  4  a),  tenascin was  mainly expressed 
within the villi, i.e., by the lamina propria (Fig. 4 b), and 
less intensely in the outer muscle layers. Around the crypts 
of Lieberkiihn, where the presumptive epithelial ceils are 
formed by continuous proliferation, tenascin could only be 
detected in low amounts in the distal regions (Fig. 4  c). 
Shift in Tenascin Chain Expression During 
Gut Development 
Isolated small intestines from various developmental stages 
were probed by Western blotting for the expression of tenas- 
cin. Fig. 5 shows the pattern obtained comparing tissue ex- 
tracts from day 13 to 18 of embryonic development as well 
as from newborn and adult stages.  An extract from cultured 
fibroblasts is shown for comparison in Fig. 5, lanefi The rel- 
ative amount of the heavy (260-kD) and light (210-kD) com- 
ponent changes significantly during the development. While 
almost no 260-kD band is observed at day 15 of embryonic 
development, this band becomes more pronounced around 
birth, and is clearly present in the adult. However, it did not 
The Journal of Cell Biology,  Volume 107, 1988  2344 Figure 4. Distribution  of fibronectin and tenascin in the adult duodenum (a and b) and ileum (c). In the duodenum, large areas of intestinal 
glands (ig) are seen around the lumen.  At the base of the villi (c) the crypts of Lieberkiihn  (cry) can be recognized.  In these crypts, new 
cells are continuously produced by proliferation,  which then differentiate  and migrate along the villus' surface towards its tip, where they 
are shed into the lumen.  Tenascin  is only very weakly expressed  around the intestinal  glands  (b) and the crypts (c),  but is prominent in 
the villus core and especially  in the region of the subepithelial  fibroblasts  (c, arrowhead). Expression  of the protein  by smooth muscle 
cells  in the muscularis  externa  is also seen.  Fibronectin,  in contrast, is present  in all mesenchymal  regions  (a).  Bars: (a and b) 30 ~tm; 
(c) 60 lam. 
become as pronounced as in cultured fibroblasts.  In immu- 
noblots  as  well  as  in  immunoprecipitates  from  tissue  ex- 
tracts, we frequently observed a resolution of both the upper 
and the lower component into two bands.  This was not ob- 
served  in  tenascin  from fibroblasts.  While  the  split  of the 
smaller band has been previously described for chick (8) and 
human (19) tenascin, the separation of the larger component 
into two bands  seems to be novel. 
Induction of Tenascin Expression in Isolated 
Mesenchymes by Epithelial Cells in Transfilter Culture 
The  immunofluorescence  data  showed  a  relationship  be- 
tween the onset of epithelial differentiation and tenascin ex- 
pression.  This  raised  the  question  of whether  the  mesen- 
chyme  starts  to  expresses  tenascin  independently  of  the 
epithelium,  or whether  interactions  between these two tis- 
sues are needed.  To study this,  we combined isolated  13-d 
gut mesenchymes  with  cultures  of embryonic cell  lines  in 
a  transfilter  set-up,  with  tissue  and  cells  separated  by the 
filter.  When gut mesenchymes were cultured alone on filters 
coated with gelatin, or in coculture with B16-F1 melanoma, 
almost no tenascin  could be detected  by immunoprecipita- 
tion.  However, when the mesenchymes were confronted for 
24 h  with the canine epithelial  cell  line,  MDCK, abundant 
synthesis of tenascin could be detected, with a clear predom- 
inance  of the  heavy  subunit  (Fig.  6).  Neither  the  B16-F1 
melanoma cells  nor the MDCK cells  themselves produced 
tenascin.  The results  were verified by immunofluorescence 
analysis of the mesenchyme. The morphological data showed 
that tenascin  was deposited  into the  matrix  of the  mesen- 
chyme as fibers around the cells only in those explants which 
had been cocultured with the MDCK cells (Fig. 7 c) but not 
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sates with mAb MTn 12. Segments of  the intestine directly adjacent 
to the stomach were extracted in a buffer at pH 11.5. Embryonic 
mouse fibroblasts were scraped off  the plate and directly boiled in 
sample buffer. Extracts were then separated by SDS-PAGE (linear 
5-10% acrylamide gradient), transferred to nitrocellulose, and de- 
tected by sequential incubation with the mAb, a biotinylated second 
antibody, a streptavidin-alkaline phosphate complex, and a color 
reaction. Extracts are from embryonic days 13 (lane 1), 15 (lane 
2),  17 (lane 3), and 18 (lane 4), as well as from newborn (lane 5) 
and adult (lane 6) tissues. An immunoblot of a fibroblast lysate 
(lane 7) is shown for comparison. 
in explants cultured alone or together with B16-F1 melanoma 
cells (Fig. 7, a  and b). 
Discussion 
Several lines of evidence support the hypothesis that epithe- 
lial  cells  stimulate  nearby mesenchymal cells  to  produce 
tenascin. In a previous paper (1) it was shown that tenascin 
expression appeared in embryonic kidney mesenchyme short- 
ly after the first epithelial-mesenchymal interactions. In the 
present report, using mAbs, we show that an epithelial cell 
line can stimulate embryonic gut mesenchyme to produce 
tenascin. This response of the mesenchyme could be a physi- 
ological one  since  it mimics  normal  embryonic develop- 
ment. We found that the gut embryonic mesenchyme during 
normal development starts to produce tenascin when epithe- 
lial-mesenchymal interactions occur. 
The data described here suggest that cellular cooperation 
is involved in the control of mesenchymal extracellular ma- 
trix synthesis. The importance of heterotypic cellular inter- 
actions has been previously clearly shown for the develop- 
ment of the basement membrane of the epithelial cells in 
many embryonic tissues (2, 3, 15,  16, 28, 30, 42), including 
the gut (23, 43). Less is known about the possible regulation 
of the mesenchymal extracellular matrix by the epithelium. 
Figure  6.  Stimulation of tenascin 
synthesis in embryonic gut mesen- 
chyme by epithelial cells. Immuno- 
precipitation of  tenascin from mes- 
enchymes  cultured  for 24 h on either 
Nuclepore  filters  (pore  size,  1.0 
I~m) alone (lane 1), or Nuclepore 
filters coated on their  other  side 
with either B16-F1 melanoma cells 
(lane 2) or MDCK epithelial cells 
(lane 3).  Gut mesenchymes were 
isolated from 13-d embryos. After 
the culture period,  mesenchymes 
were removed from the filters and 
then labeled for 4 h with 37 MBq/ 
ml [35S]methionine and 3.7 MBq/ 
ml [3H]leucine. 
This is largely because of a  lack of characterized mesen- 
ehymal extracellular matrix components with a  restricted 
distribution.  Consequently,  there have been no probes to 
study such components. We have here characterized mAbs 
against mouse tenascin, a mesenchymal protein with a more 
restricted tissue  distribution  than other described mesen- 
chymal matrix proteins (5,  7,  8,  10,  11, 34,  35,  44). 
With only a  few exceptions (11, 24),  previous investiga- 
tions on the expression of tenascin in embryonic tissues have 
been based largely on immunohistological approaches (1, 10, 
34, 35). Analysis of tenascin directly from tissues by immu- 
noblotting or immunoprecipitation was hampered by the lack 
of an appropriate procedure for extraction of tenascin from 
tissues  (8)  and by the  fact that the commonly used anti- 
chicken tenascin antibodies (8, 10) reacted poorly in Western 
blotting  (unpublished observations).  Our mAbs  overcome 
this problem and by using a modification of extraction proce- 
dures described by Crossin et al. (11), it was possible to de- 
tect tenascin directly from tissue extracts in immunoblots. 
The mAbs reacted with two components of tenascin, with an 
Mr  of 210  and  260  kD,  respectively. Previously, tenascin 
and related proteins such as glioma mesenchymal extracellu- 
lar matrix antigen (4), hexabrachion (18), and cytotactin (21) 
could be shown to be composed of a predominant subunit of 
220 kD from chicken (8) and 250-285 kD from human 
sources (5,  18).  Bands of "~210 kD for the human protein 
(19),  which were weak enough to escape discovery in the 
original publications (18), and bands of '~190-200 kD for 
chicken tenascin were reported as minor components. Our 
results on mouse gut development show that the predomi- 
nance of the larger subunit is not an invariable feature of 
tenascin. While the 210-kD light chain is strongly predomi- 
nant at the early developmental stages  in the embryo, the 
260-kD heavy chain becomes more pronounced around birth 
and especially in the adult intestine.  A  similar gradual in- 
crease in the relative amount of the heavier chain has been 
shown for cytotactin in developing chick brain (24). It has 
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lated gut mesenchymes stimulated by MDCK epithelial cells. Iso- 
lated mesenchymes were cultured for 24 h on Nuclepore filters 
(pore size, 1.0 gin), which had been coated on their opposite side 
with either no cells (a), B16-F1 melanoma cells (b), or MDCK epi- 
thelial cells (c). Cryostat sections were stained with mAb MTn 12. 
Bar, 30 Ixm. 
been  shown  that  there  are  different  forms  of cytotactin 
mRNA (26), suggesting that the detection of isoforms is due 
to differential synthesis rather than to differences in extract- 
ability. 
Recently, the distribution of "J-l",  a  mouse protein that 
shares some characteristics with tenascin (29), has been de- 
scribed in the adult mouse ileum (45).  The distribution of 
tenascin  and  J-1  in  the adult  intestine shows  similarities, 
but the molecular mass is somewhat different. In this tissue, 
J-1  consists of peptides with apparent molecular masses of 
250 and  170 kD (45). When we purify tenascin by affinity 
chromatography using our mAbs, we elute a protein of 160- 
170 kD by high salt conditions, while tenascin can only be 
eluted under denaturing conditions.  If the smaller protein 
was identical with the second band of"J-l" this would mean 
that the two bands of"J-l" represent unrelated, though asso- 
ciated, proteins. Recent studies on cytotactin, which shares 
some  similarity with  "J-l",  also  suggest that  160/180-kD 
peptides  recognized by the original  antibodies against cy- 
totactin may be unrelated to true tenascin.  The more spe- 
cific antibodies raised against highly purified cytotactin (24) 
showed a reaction pattern very similar to our mAbs against 
mouse tenascin.  The available evidence thus suggests that 
larger peptides of tenascin, cytotactin, glioma mesenchymal 
extracellular matrix antigen, and hexabrachion are identical 
proteins with two major subunits, whereas the 160/180-kD 
peptides of "J-l" may represent associated proteins. 
The presence of different subunits of proteins that affect 
cell adhesion is not a unique feature of tenascin; it has been 
noted for several extracellular matrix proteins (25,  36) and 
some cell adhesion molecules. The chains can be uncoor- 
dinately expressed (36).  Such variations in composition of 
the protein may have profound effects on the biological activ- 
ity of  the protein, as shown for the neural cell adhesion mole- 
cule (13)  and more recently also for laminin,  a  basement 
membrane protein (28). It is tempting to speculate that the 
changes in the different forms of tenascin, shown to occur 
during gut development, may also lead  to changes  in the 
function of the protein. 
The appearance of tenascin in the gut mesenchyme was 
verified by immunohistological means. It is notable that ten- 
ascin  was  not detectable from the early gut anlage,  even 
though the endodermal cells are already characterized as epi- 
thelial cells. It then appeared as soon as signs of differentia- 
tion  towards  the  intestinal  epithelial  structures  with  their 
diversity of cell types became obvious. It is this diversifica- 
tion that requires epithelial-mesenchymal interactions (22, 
32).  The results show that tenascin expression during gut 
development is linked to rather late stages of embryonic dif- 
ferentiation, to the formation of absorptive capacity of epi- 
thelial cells. In the adult gut, tenascin expression is also as- 
sociated with the later stages of epithelial cell differentiation. 
These findings are in accordance with results from the de- 
veloping kidney (1). 
The expression data both from the developing kidney and 
gut strongly suggest that tenascin is not mediating the first 
epithelial-mesenchymal interactions, but rather that it ap- 
pears in the mesenchyme as a consequence of it.  We have 
previously shown that inhibition of epithelial cell differentia- 
tion by an unspecific inhibitor of morphogenesis, heparin, 
suppresses tenascin expression in the mesenchyme (1). Al- 
though this supports the view that epithelial cells influence 
tenascin production of mesenchyme, the evidence was  in- 
direct.  We therefore developed a model system, which al- 
lowed us to directly probe the effect of epithelial vs.  non- 
epithelial cells.  In this  system, isolated gut mesenchymes 
were either cultured alone or in  coculture with epithelial 
(MDCK)  cells  or nonepithelial cells  (B16-Fl-melanoma). 
Tenascin expression in these mesenchymes was specifically 
triggered by the epithelial, but not the nonepithelial cells. 
The fact that B16-Fl-melanoma cells did not induce tenascin 
appearance excludes the possibility that the inductive stimu- 
lus exerted by the MDCK cells is a nonspecific effect of im- 
mortalized cells. Hence, the triggering signal may be specific 
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rived from dog kidney tubules,  can affect mouse intestinal 
mesenchymes,  shows that the signal seems to be conserved 
between different tissues and species, though the molecular 
form of tenascin produced after stimulation by MDCK cells 
is different from the one seen in situ. A similar lack of spe- 
cies and tissue specificity has been demonstrated for the re- 
verse process, the signal transmission from mesenchyme to 
epithelium, during development of both the gut (27) and the 
mammary gland (40). However examples of more stringent 
species and tissue requirements for these interactions  have 
also been reported (12).  The coculture model system used 
here should make it possible to study the effect of both em- 
bryonic and malignant epithelial cells and their growth fac- 
tors on matrix production by  mesenchymal  cells in more 
detail. 
The role of tenascin in epithelial-mesenchymal  interac- 
tions remains unknown. It was proposed by Chiquet-Ehris- 
mann et al. (10) that tenascin may support epithelial morpho- 
genesis.  It should be kept in mind that tenascin could act 
primarily on the mesenchyme rather than on the epithelium. 
Indeed, it was recently shown that tenascin influences the be- 
havior of fibroblast cells. Tenascin can counteract the action 
of fibronectin and consequently cells attach less avidly to the 
substratum  (9, 24, 34). Embryonic mesenchyme containing 
tenascin  differs  morphologically  from adult  stroma.  It  is 
more loose, a feature which may be of importance for a tissue 
which is rapidly remodelled. One possibility is that tenascin 
directly  loosens  up  the  mesenchymal  tissue  compartment 
during the epithelial-mesenchymal interactions.  Such an ef- 
fect may  indirectly  facilitate  cell migration  and epithelial 
branching,  two events  associated with tenascin expression 
(10, 35, 44). 
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